Literature DB >> 30255460

Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al.

Elizabeth D Brooks1,2, Priya S Kishnani1, Dwight D Koeberl3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30255460      PMCID： PMC6501822          DOI： 10.1007/s10545-018-0248-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  2 in total

1.  Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.

Authors:  Young Mok Lee; Thomas J Conlon; Andrew Specht; Kirsten E Coleman; Laurie M Brown; Ana M Estrella; Monika Dambska; Kathryn R Dahlberg; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2018-05-25       Impact factor: 4.982

2.  Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.

Authors:  Elizabeth D Brooks; Dustin J Landau; Jeffrey I Everitt; Talmage T Brown; Kylie M Grady; Lauren Waskowicz; Cameron R Bass; John D'Angelo; Yohannes G Asfaw; Kyha Williams; Priya S Kishnani; Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2018-07-24       Impact factor: 4.982
  2 in total
  2 in total

Review 1.  Gene therapy for glycogen storage diseases.

Authors:  Priya S Kishnani; Baodong Sun; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

2.  Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.

Authors:  Hye-Ri Kang; Monika Gjorgjieva; Stephanie N Smith; Elizabeth D Brooks; Zelin Chen; Shawn M Burgess; Randy J Chandler; Lauren R Waskowicz; Kylie M Grady; Songtao Li; Gilles Mithieux; Charles P Venditti; Fabienne Rajas; Dwight D Koeberl
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-11       Impact factor: 6.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.